An investigation of heat shock protein 27 and P-glycoprotein mediated multi-drug resistance in breast cancer using liquid chromatography-tandem mass spectrometry-based targeted proteomics

Journal of Proteomics

Volumn 108, Issue , 2014, Pages 188-197

  Xu, Feifei ^a   Yang, Ting ^a   Fang, Danjun ^a   Xu, Qingqing ^a   Chen, Yun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Heat shock protein 27 (HSP27); Liquid chromatography tandem mass spectrometry; Multi drug resistance; P glycoprotein (P gp); Phosphorylation; Targeted proteomics

Indexed keywords

DOXORUBICIN; HEAT SHOCK PROTEIN 27; MULTIDRUG RESISTANCE PROTEIN; ABCB1 PROTEIN, HUMAN; ANTINEOPLASTIC ANTIBIOTIC; HSPB1 PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; BREAST CANCER; BREAST CELL; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG SENSITIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEOMICS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; STOICHIOMETRY; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING; BREAST TUMOR; DRUG RESISTANCE; FEMALE; GENETICS; METABOLISM; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HSP27 HEAT-SHOCK PROTEINS; HUMANS; NEOPLASM PROTEINS; P-GLYCOPROTEINS; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 84902441206     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.05.016     Document Type: Article

References (41)

1. Lage H. An overview of cancer multidrug resistance: a still unsolved problem. Cell Mol Life Sci 2008, 65:3145-3167.
2. Doyle L.A., Yang W., Abruzzo L.V., Krogmann T., Gao Y., Rishi A.K., et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A 1998, 95:15665-15670.
3. Kanagasabai R., Krishnamurthy K., Druhan L.J., Ilangovan G. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in adriamycin-resistant human breast cancer cells. J Biol Chem. 2011, 286:33289-33300.
4. Dai S., Jia Y., Wu S.L., Isenberg J.S., Ridnour L.A., Bandle R.W., et al. Comprehensive characterization of heat shock protein 27 phosphorylation in human endothelial cells stimulated by the microbial dithiole thiolutin. J Proteome Res 2008, 7:4384-4395.
5. Rogalla T., Ehrnsperger M., Preville X., Kotlyarov A., Lutsch G., Ducasse C., et al. Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation. J Biol Chem 1999, 274:18947-18956.
6. Landry J., Lambert H., Zhou M., Lavoie J.N., Hickey E., Weber L.A., et al. Human HSP27 is phosphorylated at serines 78 and 82 by heat shock and mitogen-activated kinases that recognize the same amino acid motif as S6 kinase II. J Biol Chem 1992, 267:794-803.
7. Tetu B., Brisson J., Landry J., Huot J. Prognostic significance of heat-shock protein-27 in node-positive breast carcinoma: an immunohistochemical study. Breast Cancer Res Treat 1995, 36:93-97.
8. Garrido C., Brunet M., Didelot C., Zermati Y., Schmitt E., Kroemer G. Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle 2006, 5:2592-2601.
9. Xu Y., Diao Y., Qi S., Pan X., Wang Q., Xin Y., et al. Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis. Cell Signal. 2013, 25:1176-1185.
10. Barnidge D.R., Dratz E.A., Martin T., Bonilla L.E., Moran L.B., Lindall A. Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards. Anal Chem 2003, 75:445-451.
11. Shaikh A., Seegmiller J.C., Borland T.M., Burns B.E., Ladwig P.M., Singh R.J., et al. Comparison between immunoturbidimetry, size-exclusion chromatography, and LC-MS to quantify urinary albumin. Clin Chem 2008, 54:1504-1510.
12. Charette S.J., Lambert H., Nadeau P.J., Landry J. Protein quantification by chemiluminescent Western blotting: elimination of the antibody factor by dilution series and calibration curve. J Immunol Methods. 2010, 353:148-150.
13. Marx H., Lemeer S., Schliep J.E., Matheron L., Mohammed S., Cox J., et al. A large synthetic peptide and phosphopeptide reference library for mass spectrometry-based proteomics. Nat Biotechnol. 2013, 31:557-564.
14. Method of the year 2012. Nat Methods 2013, 10:1.
15. Elschenbroich S., Kislinger T. Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery. Mol Biosyst 2011, 7:292-303.
16. Kiyonami R., Schoen A., Prakash A., Peterman S., Zabrouskov V., Picotti P., et al. Increased selectivity, analytical precision, and throughput in targeted proteomics. Mol Cell Proteomics 2011, 10. [M110 002931].
17. Calvo E., Camafeita E., Fernandez-Gutierrez B., Lopez J.A. Applying selected reaction monitoring to targeted proteomics. Expert Rev Proteomics 2011, 8:165-173.
18. Kamiie J., Ohtsuki S., Iwase R., Ohmine K., Katsukura Y., Yanai K., et al. Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria. Pharm Res 2008, 25:1469-1483.
19. Atrih A., Turnock D., Sellar G., Thompson A., Feuerstein G., Ferguson M.A., et al. Stoichiometric quantification of Akt phosphorylation using LC-MS/MS. J Proteome Res. 2010, 9:743-751.
20. Yang T., Xu F., Xu J., Fang D., Yu Y., Chen Y. Comparison of liquid chromatography-tandem mass spectrometry-based targeted proteomics and conventional analytical methods for the determination of p-glycoprotein in human breast cancer cells. J Chromatogr B 2013, 936:18-24.
21. Hedges J.C., Dechert M.A., Yamboliev I.A., Martin J.L., Hickey E., Weber L.A., et al. A role for p38MAPK/HSP27 pathway in smooth muscle cell migration. J Biol Chem 1999, 274:24211-24219.
22. Food and Drug Administration FR Guidance for industry on bioanalytical method validation 2001, 66(100):28526. [(Docket no. 28598D-21195), Published].
23. Rigalli J.P., Ruiz M.L., Perdomo V.G., Villanueva S.S., Mottino A.D., Catania V.A. Pregnane X receptor mediates the induction of P-glycoprotein by spironolactone in HepG2 cells. Toxicology. 2011, 285:18-24.
24. Pan L., Iliuk A., Yu S., Geahlen R.L., Tao W.A. Multiplexed quantitation of protein expression and phosphorylation based on functionalized soluble nanopolymers. J Am Chem Soc. 2012, 134:18201-18204.
25. Deutsch E.W., Lam H., Aebersold R. PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows. EMBO Rep 2008, 9:429-434.
26. MacLean B., Tomazela D.M., Shulman N., Chambers M., Finney G.L., Frewen B., et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 2010, 26:966-968.
27. Stensballe A., Jensen O.N., Olsen J.V., Haselmann K.F., Zubarev R.A. Electron capture dissociation of singly and multiply phosphorylated peptides. Rapid Commun Mass Spectrom 2000, 14:1793-1800.
28. Moyer S.C., Cotter R.J., Woods A.S. Fragmentation of phosphopeptides by atmospheric pressure MALDI and ESI/Ion trap mass spectrometry. J Am Soc Mass Spectrom 2002, 13:274-283.
29. Previs M.J., VanBuren P., Begin K.J., Vigoreaux J.O., LeWinter M.M., Matthews D.E. Quantification of protein phosphorylation by liquid chromatography-mass spectrometry. Anal Chem 2008, 80:5864-5872.
30. Hustoft H.K., Malerod H., Wilson S.R., Reubsaet L., Lundanes E., Greibrokk T. A critical review of trypsin digestion for LC-MS based proteomics, integrative proteomics 2012, Tech, [Available from: http://www.intechopen.com/books/integrative-proteomics/a-critical-review-of-trypsin-digestion-for-lc-ms-based-proteomics]. 10.5772/29326. H.-C. Leung (Ed.).
31. Peters H.L., Hou X., Jones B.T. Multi-analyte calibration curve for high-performance liquid chromatography with an inductively coupled plasma carbon emission detector. Appl Spectrosc 2003, 57:1162-1166.
32. Guidance for industry: bioanalytical method validation 2001, http://www.fda.gov/downloads/Drugs/Guidances/ucm070107.pdf, US Department of Health and Human Services, Food and Drug Administration.
33. Balogh L.M., Kimoto E., Chupka J., Zhang H., Lai Y. membrane protein quantification by peptide-based mass spectrometry approaches: studies on the organic anion-transporting polypeptide family. Proteomics Bioinformatics 2012, S4:1-8.
34. Kuhn E., Wu J., Karl J., Liao H., Zolg W., Guild B. Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics 2004, 4:1175-1186.
35. Wang X., Pan L., Mao N., Sun L., Qin X., Yin J. Cell-cycle synchronization reverses taxol resistance of human ovarian cancer cell lines. Cancer Cell Int. 2013, 13:77.
36. Concannon C.G., Gorman A.M., Samali A. On the role of Hsp27 in regulating apoptosis. Apoptosis 2003, 8:61-70.
37. Wu R., Dephoure N., Haas W., Huttlin E.L., Zhai B., Sowa M.E., et al. Correct interpretation of comprehensive phosphorylation dynamics requires normalization by protein expression changes. Mol Cell Proteomics. 2011, 10. M111 009654.
38. Huot J., Roy G., Lambert H., Landry J. Coinduction of hsp27 phosphorylation and drug-resistance in Chinese-hamster cells. Int J Oncol 1992, 1:31-36.
39. Tremolada L., Magni F., Valsecchi C., Sarto C., Mocarelli P., Perego R., et al. Characterization of heat shock protein 27 phosphorylation sites in renal cell carcinoma. Proteomics 2005, 5:788-795.
40. Gonzalez-Mejia M.E., Voss O.H., Murnan E.J., Doseff A.I. Apigenin-induced apoptosis of leukemia cells is mediated by a bimodal and differentially regulated residue-specific phosphorylation of heat-shock protein-27. Cell Death Dis. 2010, 1:e64.
41. Xu L., Chen S., Bergan R.C. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer. Oncogene 2006, 25:2987-2998.